| answer text |
<p>When an immunotherapy treatment has been approved by the National Institute for
Health and Care Excellence (NICE), all relevant providers are required to implement
NICE’s guidance and make the treatment available for patients on the National Health
Service.</p><p>The NHS Long Term Plan sets out our commitment to making safer and
more precise treatments, including advanced radiotherapy techniques and immunotherapies,
available on the NHS to support improvements in survival rates.</p>
|
 |
